Xudong Zhao

7PUBLICATIONS
15CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 28, 2026
Correction: Granzyme B-based CAR-T cells targeting membrane-bound HSP70 suppress solid tumor growth and metastasis.

|Apr 18, 2026
Granzyme B-based CAR-T cells targeting membrane-bound HSP70 suppress solid tumor growth and metastasis.

|Aug 28, 2024
A novel bispecific T-cell engager using the ligand-target csGRP78 against acute myeloid leukemia.

Xiaozhu Zeng, Hang Zhang, Jing Guo

|Apr 18, 2024
Mesothelin-based CAR-T cells exhibit potent antitumor activity against ovarian cancer.

Jing Guo, Xiaozhu Zeng, Yongjie Zhu

|Aug 16, 2023
NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates.

Dong Yang, Bin Sun, Shirong Li

|Jul 22, 2023
Chimeric antigen receptor T cells targeting cell surface GRP78 efficiently kill glioblastoma and cancer stem cells.

Shijie Wang, Wenwen Wei, Yuncang Yuan

Pageof 2

Frequent Collaborators

3 joint publications

Dong Yang

2 joint publications

Weimin Li

2 joint publications

Peng Shi

2 joint publications

Panwen Tian